Whitehawk Therapeutics, Inc. (WHWK) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.25
• Market Cap: $155.52M
• EPS: $-0.64
• 52-Week High: $3.77
• 52-Week Low: $1.39

Market Sentiment

Whitehawk Therapeutics, Inc. currently has a Bullish sentiment score of 0.28.

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc. is a pioneering oncology therapeutics company headquartered in Morristown, New Jersey, dedicated to transforming cancer treatment through its proprietary technologies that enhance tumor biology understanding. The firm is focused on developing targeted therapies that optimize patient outcomes by personalizing treatment strategies based on the specific biological profiles of individual tumors. With its strong commitment to precision medicine, Whitehawk is poised to ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Whitehawk Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does WHWK pay dividends?

Whitehawk Therapeutics, Inc. (WHWK) does not currently pay a regular dividend.

What is WHWK's market cap?

Whitehawk Therapeutics, Inc. (WHWK) has a market capitalization of $155.52M with a current stock price of $3.25.